UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000030505 |
|---|---|
| Receipt number | R000034824 |
| Scientific Title | TR study of "multicenter Phase II study to evaluate efficacy and safety of combination therapy with trastuzumab and pertuzumab in patients with HER2-positive metastatic colorectal cancer" |
| Date of disclosure of the study information | 2017/12/21 |
| Last modified on | 2023/12/26 10:23:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/12/21 15:14:08 | ||
| 2 | Update | 2019/12/23 09:15:10 | ||
| 3 | Update | 2019/12/23 09:17:58 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 4 | Update | 2019/12/23 09:20:34 | Date of IRB Last follow-up date |
|
| 5 | Update | 2020/06/22 09:49:14 | Recruitment status |
|
| 6 | Update | 2023/12/26 10:20:52 | ||
| 7 | Update | 2023/12/26 10:23:01 | Number of participants that the trial has enrolled |
